Abatacept

Details

Files

Generic Name:

Abatacept

Project Status:

Complete

Therapeutic Area:

Arthritis, Rheumatoid

Manufacturer:

Bristol-Myers Squibb Canada

Brand Name:

Orencia

Project Line:

Reimbursement Review

Project Number:

SR0187-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Resubmission

Indications:

Arthritis, Rheumatoid

Recommendation Type:

List in a similar manner

Final Recommendation:

June 17, 2010

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : December 2, 2009